Bioanalytical Services for Clinical Studies

Bioanalytical studies are critical in any drug discovery and development program. Studies that require bioanalytical support include bioavailability (BA)/bioequivalence (BE), non-clinical pharmacokinetics (PK)/ toxicokinetics (TK), anti-drug antibody assays (ADA), and biomarker evaluation. We use an array of strategies starting from Ligand binding assays (LBAs) such as ELISA, LC-MS/MS, LC-HRMS, and hybrid LC-MS or immunoaffinity-LC-MS.

We are a CLIA and CAP certified Research Laboratory equipped with state-of-the-art facilities. We offer a wide range of testing services, including molecular diagnostics, genetic testing, and bioanalytical services, including biomarker analysis, all performed with cutting-edge technology and rigorous quality assurance. Our expert team is dedicated to delivering accurate, reliable, and timely results tailored to meet the specific needs of your clinical trials and research studies. Partner with us for unparalleled quality and service in advancing healthcare and scientific discovery.